Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

Abstract

LOMS differed clinically from AOMS. One-third of older relapsing-onset MS patients were prescribed a DMD. IFNβ exposure was not significantly associated with reduced disability in older MS patients.